Emergent BioSolutions, Prokarium deal

Prokarium acquired Emergent's Typhella Salmonella-based typhoid vaccine and spi-VEC genetic technology. Prokarium said it plans to combine Typhella and spi-VEC with its genetic and formulation technologies to form Vaxonella, an oral vaccine delivery platform that uses attenuated Salmonella, which the company then plans to license. Details were not disclosed. ...